| Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma S Richter, L Gieldon, Y Pang, M Peitzsch, T Huynh, R Leton, B Viana, ... Genetics in Medicine 21 (3), 705-717, 2019 | 82 | 2019 |
| Targeting NAD+/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma Y Pang, Y Lu, V Caisova, Y Liu, P Bullova, TT Huynh, Y Zhou, D Yu, ... Clinical Cancer Research 24 (14), 3423-3432, 2018 | 73 | 2018 |
| Calcium signaling involvement in cadmium-induced astrocyte cytotoxicity and cell death through activation of MAPK and PI3K/Akt signaling pathways JH Jiang, G Ge, K Gao, Y Pang, RC Chai, XH Jia, JG Kong, ACH Yu Neurochemical research 40, 1929-1944, 2015 | 70 | 2015 |
| Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha C Zhang, C Yang, MJ Feldman, H Wang, Y Pang, DM Maggio, D Zhu, ... Oncotarget 8 (34), 56110, 2017 | 64 | 2017 |
| Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints A Bezawork-Geleta, H Wen, LF Dong, B Yan, J Vider, S Boukalova, ... Nature communications 9 (1), 2221, 2018 | 60 | 2018 |
| Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy Y Lu, Y Liu, Y Pang, K Pacak, C Yang Pharmacology & therapeutics 188, 168-175, 2018 | 51 | 2018 |
| Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies Y Pang, Y Liu, K Pacak, C Yang Cancers 11 (4), 436, 2019 | 41 | 2019 |
| 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma D Taïeb, A Jha, C Guerin, Y Pang, KT Adams, CC Chen, P Romanet, ... The Journal of Clinical Endocrinology & Metabolism 103 (4), 1574-1582, 2018 | 41 | 2018 |
| Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid Y Liu, Y Pang, B Zhu, O Uher, V Caisova, TT Huynh, D Taieb, ... Clinical Cancer Research 26 (14), 3868-3880, 2020 | 36 | 2020 |
| Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway Y Pang, C Yang, J Schovanek, H Wang, P Bullova, V Caisova, G Gupta, ... Oncotarget 8 (14), 22313, 2017 | 36 | 2017 |
| Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas PW Wallace, C Conrad, S Brückmann, Y Pang, E Caleiras, M Murakami, ... The Journal of pathology 251 (4), 378-387, 2020 | 35 | 2020 |
| Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma Y Liu, Y Pang, V Caisova, J Ding, D Yu, Y Zhou, TT Huynh, H Ghayee, ... Cancers 12 (2), 280, 2020 | 34 | 2020 |
| Selective 14-3-3γ induction quenches p-β-catenin Ser37/Bax-enhanced cell death in cerebral cortical neurons during ischemia XJ Lai, SQ Ye, L Zheng, L Li, QR Liu, SB Yu, Y Pang, S Jin, Q Li, ACH Yu, ... Cell Death & Disease 5 (4), e1184-e1184, 2014 | 32 | 2014 |
| The significant reduction or complete eradication of subcutaneous and metastatic lesions in a pheochromocytoma mouse model after immunotherapy using mannan-BAM, TLR ligands … V Caisova, L Li, G Gupta, I Jochmanova, A Jha, O Uher, TT Huynh, ... Cancers 11 (5), 654, 2019 | 31 | 2019 |
| Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma K Hadrava Vanova, Y Pang, L Krobova, M Kraus, Z Nahacka, ... JNCI: Journal of the National Cancer Institute 114 (1), 130-138, 2022 | 27 | 2022 |
| A Transgenic Mouse Model of Pacak–Zhuang Syndrome with An Epas1 Gain-of-Function Mutation H Wang, J Cui, C Yang, JS Rosenblum, Q Zhang, Q Song, Y Pang, ... Cancers 11 (5), 667, 2019 | 27 | 2019 |
| Tumor mutational burden and immunotherapy in gliomas M Merchant, A Ranjan, Y Pang, G Yu, O Kim, J Khan, J Wu Trends in cancer 7 (12), 1054-1058, 2021 | 26 | 2021 |
| Targeting CDK9 for the treatment of glioblastoma A Ranjan, Y Pang, M Butler, M Merchant, O Kim, G Yu, YT Su, MR Gilbert, ... Cancers 13 (12), 3039, 2021 | 23 | 2021 |
| Deletion of the von Hippel-Lindau gene in hemangioblasts causes hemangioblastoma-like lesions in murine retina H Wang, MJ Shepard, C Zhang, L Dong, D Walker, L Guedez, S Park, ... Cancer research 78 (5), 1266-1274, 2018 | 23 | 2018 |
| Phase I study of zotiraciclib in combination with temozolomide for patients with recurrent high-grade astrocytomas J Wu, Y Yuan, DA Long Priel, D Fink, CJ Peer, TM Sissung, YT Su, ... Clinical Cancer Research 27 (12), 3298-3306, 2021 | 22 | 2021 |
Chunzhang YangNeuro-Oncology Branch, Center for Cancer Research, National Cancer Institute在 nih.gov 的电子邮件经过验证
